Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2009
10/14/2009CN100549012C Aryl- and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of FAAH enzyme inhibitors
10/14/2009CN100549008C Substituted oxazolidinones and their use in the field of blood coagulation
10/14/2009CN100549007C Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors
10/14/2009CN100549006C Mitotic kinesin inhibitors
10/14/2009CN100548992C Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
10/14/2009CN100548987C Pesticidal pyridinecarboxamide derivatives
10/13/2009US7601850 less hypercalcemic than 1a,25 dihydroxy vitamin D3; bone disorders, psoriasis
10/13/2009US7601751 N-(4-{N'-[2-(6-Bromo-1H-indol-3-yl)-acetyl]-guanidinomethyl}-2,6-dichloro-phenyl)-acetamide, for example; useful in the treatment of neurological disorders related to beta-amyloid production, particularly, treatment of Alzheimer's Disease and similar diseases
10/13/2009US7601749 Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof
10/13/2009US7601745 Nuclear factor kappa beta (NF-kB) inhibitors such as [4-(1H-Indol-3-yl)-piperidin-1-yl]-{2-[1-(pyrazine-2-carbonyl)-piperidin-4-yl]-thiazol-4-yl}-methanone
10/13/2009US7601742 Pyrrolidones with anti-HIV activity
10/13/2009US7601722 Gastrointestinal disorders; psychological disorders; neuropathic pain; cpgnition activators ; sexual disorders; chronic fatigue syndrome; sleep disorders; hyperactivity
10/13/2009US7601713 Kinase inhibitors and their uses
10/13/2009CA2560510C N-(1-arylpyrazol-4yl) sulfonamides and their use as parasiticides
10/13/2009CA2386974C Benzodiazepine derivatives for use in acute or chronic neurological disorders
10/13/2009CA2379666C Agent for preventing recurrence of cerebrovascular disorder and agent for ameliorating troubles following cerebrovascular disorder and inhibiting progress thereof
10/13/2009CA2341678C Potassium channel inhibitors and method
10/08/2009WO2009123896A1 Pyridyl derivatives as cftr modulators
10/08/2009WO2009123870A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009WO2009123164A1 Heterocyclic derivative having inhibitory activity on endothelial lipase
10/08/2009WO2009123142A1 Ultraviolet absorbent compositions
10/08/2009WO2009123141A1 Ultraviolet absorbent compositions
10/08/2009WO2009122968A1 Resin molded product and polymer film
10/08/2009WO2009122180A1 Pyrimidine derivatives capable of inhibiting one or more kinases
10/08/2009WO2009122034A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/08/2009WO2009121914A1 Substituted piperidines as therapeutic compounds
10/08/2009WO2009121872A2 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
10/08/2009WO2009121535A2 Antiproliferative compounds and therapeutic uses thereof
10/08/2009WO2008112022A8 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
10/08/2009US20090253906 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
10/08/2009US20090253887 Containing a bi(naphtho[2,3-d]-oxazole or -thiazole) 2,2"disubstituted with a hydroxyphenyl-, alkoxyphenyl- or glycidyloxyphenyl group or derivative; cured polyepoxides are free of fillers and excellent in linear expansion coefficient, tensile strength, and elongation
10/08/2009US20090253762 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
10/08/2009US20090253760 Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity
10/08/2009US20090253759 Tetralin analogs having sphingosine 1-phosphate agonist activity
10/08/2009US20090253745 Modulators of ocular oxidative stress
10/08/2009US20090253700 N-'4-4(4-morpholinyl) phenyl!- '(4-piperidinyl) methyl! carboxamide derivatives and their use as glycine transporter inhibitors
10/08/2009US20090253699 Compounds for Nonsense Suppression, and Methods for Their Use
10/08/2009US20090253697 Novel Indole Derivatives, Preparation Thereof as Medicinal Products and Pharmaceutical Compositions, and Especially as KDR Inhibitors
10/08/2009US20090253694 Fused hetrocyclic compounds
10/08/2009US20090253691 Trisubstituted 1,2,4-triazoles
10/08/2009US20090253690 N-[3-(1-piperidinyl)propoxy]-pyridin-1-oxide-3-carboxamidine; cardiovascular disorders; treating dysfunction of endothelial cells
10/08/2009US20090253689 Organic Compounds
10/08/2009US20090253688 Semicarbazide derivatives as kinase inhibitors
10/08/2009US20090253685 Product comprising at least one Cdc25 phosphatase inhibitor in combination with at least one other anti-cancer agent
10/08/2009US20090253684 Leukotriene b4 inhibitors
10/08/2009US20090253679 New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7
10/08/2009US20090253676 Heteroaryl Benzamide Derivatives for Use as GLK Activators in the Treatment of Diabetes
10/08/2009US20090253673 Substituted Pyrazoles as Ghrelin Receptor Antagonists
10/08/2009US20090253656 Bcrp/abcg2 inhibitor
10/08/2009CA2720176A1 Antiproliferative compounds and therapeutic uses thereof
10/08/2009CA2720004A1 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
10/08/2009CA2719907A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009CA2719070A1 Substituted piperidines as therapeutic compounds
10/08/2009CA2718488A1 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/08/2009CA2718310A1 Pyridyl derivatives as cftr modulators
10/08/2009CA2685716A1 Compounds for treating muscular dystrophy
10/07/2009EP2107054A1 Antiproliferative compounds and therapeutic uses thereof
10/07/2009EP2106400A2 Benzoquinazole derivatives
10/07/2009EP2106399A2 Imidazole derivatives as kinesin spindle protein inhibitors (eg-5)
10/07/2009EP1309566B1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors
10/07/2009CN101553486A Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators
10/07/2009CN101553476A Mitotic kinesin inhibitors and methods of use thereof
10/07/2009CN101553471A 抗菌喹啉衍生物 Antibacterial quinoline derivatives
10/07/2009CN101553470A Antibacterial quinoline derivatives
10/07/2009CN101550134A Method for preparing 2-[1H-pyrazole-5-radical]-4H-3, 1-benzoxazine-4-ketone compound
10/07/2009CN101550104A Benzene-naphthalene diimide derivative, preparation method and its application
10/06/2009US7598389 Silylated carboxamides
10/06/2009US7598384 Specific binding is extremely high; low toxicity; high degree of activity; 2-(5-m-Tolyl-thiazol-2-yl )-7,8-dihydro-6H-quinolin-5-one, acute and/or chronic neurological disorders
10/06/2009US7598383 mitogen activated protein kinase inhibitors; 4-(2-fluoro-4-methylphenylamino)-1,3-dimethyl-6,7-dihydro-1H-pyrrolo[3,4-b]pyridine-2,5-dione; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals
10/06/2009US7598378 Reacting 4-(4-nitrophenyl)-3-morpholinone with hydrogen in the presence of a hydrogenation catalyst, characterized in that reaction is effected in an aliphatic alcohol; precursor in synthesis of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide
10/06/2009US7598377 (+-)-7-Methyl-2-morpholin-4-yl-9-(1-phenylaminoethyl)-pyrido[1,2-a]pyrimidin-4-one, for example; selective inhibitors of phosphoinositide (PI) 3-kinase beta for use in anti-thrombotic therapy
10/06/2009US7598284 Indazole compounds as B3 adrenoceptor agonist
10/06/2009US7598272 Kinase inhibitors
10/06/2009US7598268 Vascular endothelial growth factor; tyrosine kinase inhibitor;angiogenesis inhibitor; anticarcinogenic agents
10/06/2009US7598266 Fused heterocyclic derivatives as PPAR modulators
10/06/2009US7598260 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
10/06/2009US7598255 Pyrimidine compounds as serotonin receptor modulators
10/06/2009US7598251 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents
10/06/2009US7598250 for treating neurodegenerative disease such as Alzheimer's disease
10/06/2009US7598245 Pyruvate dehydrogenase kinase, c-KIT, cyclin-dependent kinases, Janus kinases, FLT3 kinase, AUR-2 kinase, tyrosine kinase; 1-(2-amino-4-pyridyl)-3-phenylaminotriazoles; combination therapy with antiallergens, immunomodulators, antiproliferative agents; Alzheimer's, Parkinson's, Multiple Sclerosis, asthma
10/06/2009US7598244 (S)-1-(3-ethoxy-1-methylpropyl)-3-[7-(3,4-methylenedioxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]urea; preventive and/or therapeutic agent for immunological rejection and/or graft versus host reaction in organ/bone marrow transplant, autoimmune disease, allergic disease and/or inflammatory disease
10/06/2009US7598243 inhibit atherosclerotic lesion formation and pathological progression by impairing monocyte recruitment and differentiation in the arterial wall; antiinflammatory, anticarcinogenic agent; autoimmune diseases
10/06/2009US7598242 Compounds for the treatment of inflammatory disorders
10/06/2009US7598237 7-aryl 1,5-dihydro-4,1-benzoxazepin-2(3H)-one derivatives and their use as progesterone receptor modulators
10/06/2009CA2488034C Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues
10/06/2009CA2301377C N-aroylphenylalanine derivatives
10/01/2009WO2009120874A2 INHIBITORS OF ANTIGEN RECEPTOR-INDUCED NF-кB ACTIVATION
10/01/2009WO2009120660A2 Substituted pyridoxazines
10/01/2009WO2009120615A2 Substituted gamma lactams as therapeutic agents
10/01/2009WO2009119880A1 Substituted pyrazole derivatives and use thereof
10/01/2009WO2009119858A1 Benzene compound, and use thereof for medical purposes
10/01/2009WO2009119776A1 Fused heterocyclic derivative and use thereof
10/01/2009WO2009119534A1 Novel tetrahydroisoquinoline derivative
10/01/2009WO2009119089A1 Nitrogen-containing heterocyclic compound and bactericide for agricultural and horticultural use
10/01/2009WO2009119088A1 Heterocyclic compound
10/01/2009WO2009118765A2 Novel monoamine re-uptake inhibitor
10/01/2009WO2009118305A1 Hydroxamate-based inhibitors of deacetylases b
10/01/2009WO2009118174A1 Substituted cyclohexyldiamines
10/01/2009WO2009117808A1 Inhibitors of histone deacetylase
10/01/2009WO2009079767A9 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer
1 ... 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 ... 647